Real-time enrollment status for this aml clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 11:05 PM UTC
| NCT Number | NCT04644016 |
| Recruiting Status | Recruiting |
| Condition | AML |
| Phase | PHASE2 |
| Target Enrollment | 31 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | March 13, 2026 (Mar 13, 2026) |
As of July 16, 2026: Clinical trial NCT04644016 is currently recruiting participants. This phase2 study for aml is actively seeking new participants at 1 location across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04644016 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04644016 was last updated Mar 13, 2026 (March 13, 2026). HelloStudys verifies this status automatically.